# Development and Clinical Application of [11C]Verapamil-PET

> **NCT02144792** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** [11C] -verapamil PET

## Key facts

- **NCT ID:** NCT02144792
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2014-05
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02144792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02144792, "Development and Clinical Application of [11C]Verapamil-PET". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT02144792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*